TMCI

Treace Medical Concepts, Inc. - Common Stock (TMCI)

About Treace Medical Concepts, Inc. - Common Stock (TMCI)

Treace Medical Concepts, Inc. engages in the designing, manufacturing, and marketing of orthopedic medical devices and biologic solutions. The firm offers Lapiplasty, a bunion surgery for three-dimensional bunion correction. It operates and distributes its products and services under the following trademarks: Treace Medical Concepts, Lapiplasty, Fast Grafter, Align My Toe, The Future of Hallux Valgus, Fix It Right The First Time, and Plantar Python. The company was founded by John T. Treace in July 2013 and is headquartered in Ponte Vedra Beach, FL.

Details

Daily high
$4.68
Daily low
$4.46
Price at open
--
52 Week High
$7.10
52 Week Low
$1.17
Market cap
292.0M
Dividend yield
-
Volume
17
Avg. volume
245,814
P/E ratio
-4.85

Treace Medical Concepts, Inc. - Common Stock News

Details

Daily high
$4.68
Daily low
$4.46
Price at open
--
52 Week High
$7.10
52 Week Low
$1.17
Market cap
292.0M
Dividend yield
-
Volume
17
Avg. volume
245,814
P/E ratio
-4.85